We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
+26.93%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105B
AUM Growth
+$9.87B
(+10%)
Cap. Flow
-$5.55B
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,219
New
117
Increased
528
Reduced
975
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$446M |
| 2 |
Cisco
CSCO
|
+$406M |
| 3 |
Snowflake
SNOW
|
+$271M |
| 4 |
Visa
V
|
+$220M |
| 5 |
APi Group
APG
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Palo Alto Networks
PANW
|
+$583M |
| 3 |
Microsoft
MSFT
|
+$480M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$474M |
| 5 |
Marvell Technology
MRVL
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.26% |
| 2 | Industrials | 13.78% |
| 3 | Healthcare | 11.68% |
| 4 | Financials | 8.38% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CVS Health
CVS
$122B
| $84.6M | 0.08% |
817,301
+263,983
| +48% | +$23.6M |
|
252
DTE Energy
DTE
$29.1B
| $84.5M | 0.08% |
554,359
-29,177
| -5% | -$4.26M |
|
253
Capital One
COF
$134B
| $83.8M | 0.08% |
417,759
-47,616
| -10% | -$9.11M |
|
254
Alnylam Pharmaceuticals
ALNY
$29.3B
| $83.3M | 0.08% |
278,613
+40,693
| +17% | +$12.3M |
|
255
Accenture
ACN
$108B
| $83M | 0.08% |
666,657
+64,091
| +11% | +$11.1M |
|
256
CME Group
CME
$94.8B
| $82.6M | 0.08% |
374,116
+88,730
| +31% | +$24.5M |
|
257
Rayonier
RYN
$6.55B
| $81.8M | 0.08% |
3,845,807
-1,079,656
| -22% | -$22.6M |
|
258
iShares TIPS Bond ETF
TIP
$14.7B
| $81.8M | 0.08% |
744,300
-747,000
| -50% | -$82.6M |
|
259
Incyte
INCY
$24.4B
| $81.3M | 0.08% |
713,354
-202,834
| -22% | -$20.1M |
|
260
AT&T
T
$163B
| $80.3M | 0.08% |
3,880,245
+745,210
| +24% | +$18.5M |
|
261
Packaging Corp of America
PKG
$22.8B
| $80.2M | 0.08% |
336,686
+8,036
| +2% | +$1.76M |
|
262
Crinetics Pharmaceuticals
CRNX
$8.92B
| $77.6M | 0.07% |
2,075,375
+191,094
| +10% | +$7.1M |
|
263
Estee Lauder
EL
$32B
| $77.5M | 0.07% |
981,668
+8,190
| +0.8% | +$662K |
|
264
Allstate
ALL
$67.5B
| $74.2M | 0.07% |
311,981
-20,068
| -6% | -$4.36M |
|
265
McKesson
MCK
$101B
| $72.8M | 0.07% |
96,394
-20,345
| -17% | -$16.1M |
|
266
Neurocrine Biosciences
NBIX
$16.6B
| $72.8M | 0.07% |
430,635
-172,008
| -29% | -$25.5M |
|
267
Denali Therapeutics
DNLI
$3.97B
| $71.9M | 0.07% |
2,791,206
+232,341
| +9% | +$4.77M |
|
268
Progressive
PGR
$125B
| $71.9M | 0.07% |
329,073
-18,404
| -5% | -$3.71M |
|
269
Xenon Pharmaceuticals
XENE
$6.12B
| $71.6M | 0.07% |
1,187,723
+508,014
| +75% | +$28.2M |
|
270
Intercontinental Exchange
ICE
$84.4B
| $71.2M | 0.07% |
578,733
+234,786
| +68% | +$35.2M |
|
271
Pentair
PNR
$11B
| $70.4M | 0.07% |
918,266
-2,988,356
| -76% | -$236M |
|
272
Tower Semiconductor
TSEM
$28.5B
| $70.2M | 0.07% |
270,065
+223,680
| +482% | +$53.6M |
|
273
Pfizer
PFE
$153B
| $69.9M | 0.07% |
2,900,775
+187,392
| +7% | +$4.9M |
|
274
O'Reilly Automotive
ORLY
$76.3B
| $69.8M | 0.07% |
757,854
-34,505
| -4% | -$3.15M |
|
275
Protagonist Therapeutics
PTGX
$9.44B
| $69.6M | 0.07% |
567,990
-13,093
| -2% | -$1.37M |
|
Similar funds
Pictet Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pictet Asset Management held 2,219 positions worth $105B, up 10% from $94.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management withdrew a net $5.55B in Q2 2026, closing 77 positions and reducing 975 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $87.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Pictet Asset Management opened a new position in Madison Air Solutions worth $173M.
- Pictet Asset Management's largest Q2 2026 buy was Madison Air Solutions: 4,434,713 shares worth $173M.
- Pictet Asset Management added most to Vertiv in Q2 2026, an estimated $446M increase.
- Pictet Asset Management's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $893M.
- Pictet Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $87.3M.
- Pictet Asset Management's ten largest holdings make up 22% of its $105B portfolio in Q2 2026.
- Pictet Asset Management opened 117 new positions and closed 77 in Q2 2026.
- Pictet Asset Management's portfolio value rose 10% quarter-over-quarter to $105B.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.